Last updated March 4, 2015


  1. Anderson RT, Morris CR, Kimmick G, et al. Patterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors. Cancer 2015;121:790-9.
  2. Cohen EL, Wilson BR, Vanderpool RC, Collins T. Identifying Sociocultural Barriers to Mammography Adherence Among Appalachian Kentucky Women. Health communication 2015:1-11.
  3. Villano JL, Durbin EB, Normandeau C, Thakkar JP, Moirangthem V, Davis FG. Incidence of brain metastasis at initial presentation of lung cancer. Neuro-oncology 2015;17:122-8.
  4. Weyl H, Yackzan S, Ross K, Henson A, Moe K, Lewis CP. Understanding colorectal screening behaviors and factors associated with screening in a community hospital setting. Clinical journal of oncology nursing 2015;19:89-93.


  1. Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2014.
  2. Flagg EW, Datta SD, Saraiya M, et al. Population-based surveillance for cervical cancer precursors in three central cancer registries, United States 2009. Cancer causes & control : CCC 2014;25:571-81.
  3. Fleming ST, Hamilton AS, Sabatino SA, et al. Treatment patterns for prostate cancer: comparison of Medicare claims data to medical record review. Medical care 2014;52:e58-64.
  4. Fleming ST, Mackley HB, Camacho F, et al. Clinical, sociodemographic, and service provider determinants of guideline concordant colorectal cancer care for Appalachian residents. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association 2014;30:27-39.
  5. Gal TS, Tucker TC, Gangopadhyay A, Chen Z. A data recipient centered de-identification method to retain statistical attributes. Journal of biomedical informatics 2014;50:32-45.
  6. Hamilton AS, Fleming ST, Wang D, et al. Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer. American journal of clinical oncology 2014.
  7. Hernandez BY, Goodman MT, Unger ER, et al. Human papillomavirus genotype prevalence in invasive penile cancers from a registry-based United States population. Frontiers in oncology 2014;4:9.
  8. Hopenhayn C, Christian A, Christian WJ, et al. Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction. Journal of lower genital tract disease 2014;18:182-9.
  9. Kimmick G, Fleming ST, Sabatino SA, et al. Comorbidity burden and guideline-concordant care for breast cancer. Journal of the American Geriatrics Society 2014;62:482-8.
  10. Long KL, Huang B, Guo J, Lee C, Sloan D, McKenzie S. Concerning trends in Appalachian patients with thyroid carcinoma. The American surgeon 2014;80:620-3.
  11. Sabatino SA, Thompson TD, Wu XC, et al. The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer. Breast cancer research and treatment 2014;146:199-209.
  12. Saha SP, Kalathiya RJ, Davenport DL, Ferraris VA, Mullett TW, Zwischenberger JB. Survival after Pneumonectomy for Stage III Non-small Cell Lung Cancer. Oman medical journal 2014;29:24-7.
  13. Sinno AK, Saraiya M, Thompson TD, et al. Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population. Obstetrics and gynecology 2014;123:817-21.
  14. Steinau M, Saraiya M, Goodman MT, et al. Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerging infectious diseases 2014;20:822-8.
  15. Thakkar JP, Dolecek TA, Horbinski C, et al. Epidemiologic and molecular prognostic review of glioblastoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014;23:1985-96.
  16. Wang D, Ho A, Hamilton AS, et al. Type and dose of radiotherapy used for initial treatment of non-metastatic prostate cancer. Radiation oncology (London, England) 2014;9:47.
  17. Zelenskiy S, Thompson CL, Tucker TC, Li L. High dietary glycemic load is associated with increased risk of colon cancer. Nutrition and cancer 2014;66:362-8.